BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 16439692)

  • 21. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK; Askew D; Boom WH; Harding CV
    J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression.
    Dong Y; Tang L; Letterio JJ; Benveniste EN
    J Immunol; 2001 Jul; 167(1):311-9. PubMed ID: 11418665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
    Chang CH; Fontes JD; Peterlin M; Flavell RA
    J Exp Med; 1994 Oct; 180(4):1367-74. PubMed ID: 7931070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta.
    Piskurich JF; Linhoff MW; Wang Y; Ting JP
    Mol Cell Biol; 1999 Jan; 19(1):431-40. PubMed ID: 9858567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
    Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
    J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RFX family interacts at the collagen (COL1A2) start site and represses transcription.
    Sengupta PK; Fargo J; Smith BD
    J Biol Chem; 2002 Jul; 277(28):24926-37. PubMed ID: 11986307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
    Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
    Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
    Xi H; Goodwin B; Shepherd AT; Blanck G
    Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
    Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
    Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
    Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
    Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smooth muscle cell: a key cell for plaque vulnerability regulation?
    Bochaton-Piallat ML; Gabbiani G
    Circ Res; 2006 Mar; 98(4):448-9. PubMed ID: 16514076
    [No Abstract]   [Full Text] [Related]  

  • 40. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.